EPA faces suit over plan to release genetically engineered mosquitoes
By Rachel Franzin,
The Hill
| 06. 15. 2020
The Center for Food Safety, the International Center for Technology Assessment and Friends of the Earth allege that the EPA violated the law.
The Environmental Protection Agency (EPA) is facing a lawsuit over its approval of a plan to release genetically modified mosquitoes in Florida and Texas.
Several groups, including the Center for Food Safety, the International Center for Technology Assessment and Friends of the Earth filed a notice of intent to sue on Friday. They alleged that the EPA violated the law by failing to consult with wildlife agencies before determining that the mosquitoes will not pose risks to threatened species.
“EPA’s ‘no effect’ findings and failure to consult are arbitrary and capricious and violate the ESA [Endangered Species Act] because they fail to follow the ESA’s mandated procedures, fail to use the best scientific and commercial data available, fail to consider significant aspects of the issue, and offer an explanation that runs counter to the evidence before the agency,” the groups claimed in their notice.
The EPA last month approved an experimental use permit for a company that wants to test the use of genetically engineered mosquitoes as a way to try to reduce mosquito populations and protect people from mosquito-borne illnesses.
According...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...